The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
The purpose of this study is to evaluate the efficacy of cryoablation use on patient-reported outcomes (PROMs) and opioid consumption following total knee arthroplasty. This is a randomized study that will involve a 1:1 randomization to total knee arthroplasty +/- cryoablation.
Eligibility criteria
Qualifiers
Patients are candidates for elective primary total knee arthroplasty for a diagnosis of osteoarthritis or inflammatory arthritis.
Patients have been medically cleared and scheduled for surgery
Disqualifiers
Patients with cold-related conditions (cryoglobulinemia, paroxysmal cold hemoglobinuria, cold urticaria, and Raynaud's disease)
Surgery for fracture, infection, or malignancy
Trial design
Treatments tested in this trial
- Total knee arthroplasty (TKA)
- Cryoablation
Treatment groups
215 Participants
are divided into 2 treatment groupsLocations
1NYU Langone Health10016, New YorkNew York, United States
Sponsors and collaborators
NYU Langone Health
Lead sponsor
Source ClinicalTrials.gov